Ephrin Receptor
Ephrin receptor inhibitors target Eph receptors, a family of receptor tyrosine kinases that interact with membrane-bound ephrin ligands. Ephrin signaling is crucial for cell positioning, tissue patterning, and angiogenesis. Dysregulation of this pathway is implicated in cancer, neurodegenerative diseases, and developmental disorders. At CymitQuimica, we provide Ephrin receptor inhibitors to support your research in developmental biology, oncology, and neurobiology.
Found 25 products of "Ephrin Receptor"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
EphA2 agonist 2
CAS:EphA2 agonist 2 (Lead compound) is a selective agonist targeting the EphA2 receptor, exhibiting antitumor properties and the ability to cross the blood-brainFormula:C40H56N10O6Color and Shape:SolidMolecular weight:772.94LDN-211904 oxalate
CAS:LDN-211904 oxalate (LDN211904 oxalate) is a selective and efficient EphB3 inhibitor with antitumor activity, useful in neurodegenerative disease research.Formula:C21H21ClN4O5Purity:99.87%Color and Shape:SolidMolecular weight:444.87UniPR505
CAS:UniPR505 is a potent EphA2 antagonist (IC50: 0.95 µM), a novel 3α-carbamoyloxy derivative with antiangiogenic properties.
Formula:C39H57N3O5Purity:98.23%Color and Shape:SolidMolecular weight:647.89UniPR1447
CAS:UniPR1447 is a dual antagonist for both EphA2 and EphB2 receptors, exhibiting an IC50 value of 6.6 μM against EphA2-ephrin-A1 binding [1].Formula:C36H50N2O4Purity:98%Color and Shape:SolidMolecular weight:574.79UniPR500
CAS:UniPR500, a derivative of UniPR129, is a competitive antagonist for the EphA2 receptor, with a Ki of 0.78 μM. It reduces the binding of biotinylated Ephrin-A1 to EphA2 in a dose-dependent manner, exhibiting an IC50 value of 1.1 μM.Formula:C36H51N3O4Color and Shape:SolidMolecular weight:589.808
